Orthofix International | OFIX - Operating Expenses


Orthofix International reported $213.79M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 140.72M 2.71M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
EDAP TMS EUR 18.8M 3.01M Sep/2025
Globus Medical USD 595.85M 49.26M Mar/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
STAAR Surgical USD 76.12M 7.38M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Veracyte USD 119.99M 3.99M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026